Company / Inventory
ImmunityBio, Inc. Inventory History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$910.0K
FY2025
5-year range
$0 / $8.3M
FY2023-FY2025
Trend
-89.0%
vs FY2024
Sector context
#102 of 105
Health Care
What the data says
Among 105 Health Care companies, ImmunityBio, Inc. is in the bottom 3% for inventory. Improved from $0 to $910,000 over the past 2 years.
Based on SEC 10-K filings.
$910,000 in FY2025.
Improved from $0 to $910,000 over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 105This company $910.0K Sector average $885.3M
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, inventory decreased 89.0% year-over-year.
- Ranks #102 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $910.0K | -89.0% |
| FY2024 | $8.3M | - |
| FY2023 | $0 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026